IL5 and Huntington disease: Regarding the Th2-type cytokines, including IL-4, IL-5, IL-10, and IL-13, the HD patients in the breakthrough infection group had higher IL-5 levels than those in the booster immunization group (p = 0.024), but there was no significant difference between the control and HD patients in either group.